Literature DB >> 12164683

Effects of glioma cells on maturation of dendritic cells.

Tetsuro Kikuchi1, Toshiaki Abe, Tsuneya Ohno.   

Abstract

We investigated whether glioma cells affected the maturation of dendritic cells (DCs). First, DCs phenotypes were analyzed using FACScan. Incubation of both human and mouse immature DCs with glioma cells altered their expression of cell surface molecules, whereas expression of cell surface molecules by mature mouse and human DCs was not affected by exposure to glioma cells. Subsequently, phagositosis was assessed by uptake of FITC-dextran. Coculture with glioma cells did not inhibit phagositosis of either mature or immature DCs relative to the controls. We also analyzed the concentration of IL-12 secreted by mature DCs using enzyme-linked immunoabsorbent assay (ELISA). IL- 12 production by DCs was inhibited by coculture with glioma cells. However, stimulation with lipopolysaccharide restored the production of IL- 12 by both human and mouse DCs. These data suggest that glioma cells suppress the maturation of DCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164683     DOI: 10.1023/a:1016009528258

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.

Authors:  K Sakamoto; H Hoshino; Y Kiuchi; G Nakano; Y Nagamachi
Journal:  Jpn J Exp Med       Date:  1989-10

2.  Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats.

Authors:  P Chaux; N Favre; M Martin; F Martin
Journal:  Int J Cancer       Date:  1997-08-07       Impact factor: 7.396

Review 3.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

4.  Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.

Authors:  M E Reeves; R E Royal; J S Lam; S A Rosenberg; P Hwu
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

5.  Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells.

Authors:  S M Kiertscher; J Luo; S M Dubinett; M D Roth
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

6.  Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.

Authors:  Y Akasaki; T Kikuchi; S Homma; T Abe; D Kofe; T Ohno
Journal:  J Immunother       Date:  2001 Mar-Apr       Impact factor: 4.456

7.  A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment.

Authors:  P J Mosca; A C Hobeika; T M Clay; S K Nair; E K Thomas; M A Morse; H K Lyerly
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

8.  Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.

Authors:  C M Celluzzi; L D Falo
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

9.  Minimal recruitment and activation of dendritic cells within renal cell carcinoma.

Authors:  A J Troy; K L Summers; P J Davidson; C H Atkinson; D N Hart
Journal:  Clin Cancer Res       Date:  1998-03       Impact factor: 12.531

10.  Decreased antigen presentation by dendritic cells in patients with breast cancer.

Authors:  D I Gabrilovich; J Corak; I F Ciernik; D Kavanaugh; D P Carbone
Journal:  Clin Cancer Res       Date:  1997-03       Impact factor: 12.531

View more
  1 in total

1.  Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival.

Authors:  Sergiy V Kushchayev; Tejas Sankar; Laura L Eggink; Yevgeniya S Kushchayeva; Philip C Wiener; J Kenneth Hoober; Jennifer Eschbacher; Ruolan Liu; Fu-Dong Shi; Mohammed G Abdelwahab; Adrienne C Scheck; Mark C Preul
Journal:  Cancer Manag Res       Date:  2012-09-17       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.